SubscribeLogin
Published

'A very worrying scenario': Internal documents on India Covid-19 vaccine raise troubling questions about approval process

Summary by Ground News
STAT review: Indian regulators endorsed Covaxin vaccine despite discrepancies in clinical trial participants. questionable changes were made to the trial protocols to expedite the approval process. Experts in public health and clinical trial design expressed concern that the vaccine may have been hastily approved. The episode may rekindle questions about the commitment by Indian government agencies.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

VaccinesVaccines
CoronavirusCoronavirus
IndiaIndia
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal